<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-14T04:26:11Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.35406" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.35406</identifier>
    <datestamp>2026-07-09T10:52:15Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-07-09</dc:date>
  <dc:title>N-3 polyunsaturated fatty acids prevent diabetic cardiomyopathy by promoting TET2-mediated DNA demethylation</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.35406</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Diabetes cardiomyopathy (DCM) has become an important complication of diabetes, and its pathogenesis is closely related to the disorder of active DNA methylation. N-3 polyunsaturated fatty acids (n-3 PUFAs) improved insulin resistance and cardiovascular function, however the underlay molecular mechanism is unknown. The mice were fed with high-fat diet and injected with STZ (55mg/kg/d) for 7 consecutive days. Diabetes mice were fed with high-fat diet for another 12 weeks to induce diabetes DCM, DCM mice were then divided into four groups: DCM group (normal saline); metformin group (MET, 150 mg/kg/d metformin buffer); low-dose n-3 PUFAs group (Ln-3, 150 mg/kg/d); high-dose n-3 PUFAs group (Hn-3, 300 mg/kg/d). The control group (CON) was fed with a standard diet (normal saline). Fasting serum concentrations of insulin, TC, TG, LDL-C, and the atherogenic index of plasma were significantly lower in both Ln-3 and Hn-3 groups than in DCM group.&amp;nbsp;Total n-3 PUFAs and n-3/n-6 n-3 PUFAs ratio in heart were significantly lower in DCM group than them in&amp;nbsp;CON, Ln-3 and Hn-3 groups. N-3 PUFAs improved cardiac contractile and diastolic functions, reduced cardiomyocyte hypertrophy and fibrosis, and enhanced cardiac function of mice. The protein expression levels of TET2 and p-AMPK&amp;alpha;/AMPK&amp;alpha; in mice heart of Hn-3 group were significantly higher than those in DCM group. The ratio of &amp;alpha;-ketoglutarate to (succinate + fumarate) in DCM group was significantly lower than that in Ln-3 and Hn-3 groups. In conclusion, n-3 PUFAs prevented the occurrence of DCM by promoting TET2-mediated DNA demethylation in diabetic mice heart.</dc:description>
  <dc:subject>N-3 polyunsaturated fatty acids; Diabetic cardiomyopathy; Ten-eleven translocation 2; Active DNA demethylation; Tricarboxylic acid cycle.</dc:subject>
  <dc:creator>Run Liu</dc:creator>
  <dc:rights>EMBARGO</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>